title: atezolizumab (mpdl3280a): harnessing immunotherapy's promise in cancer treatment | glpbio
Published 8 months ago • 35 plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
0:30
gc32704 atezolizumab (mpdl3280a)
-
4:03
atezolizumab injection explained: uses, dosage, mechanism, side effects & advice | mediinsights
-
1:08
dr. horn on the fda approval of atezolizumab plus bevacizumab and chemotherapy in nsclc
-
7:32
the promise of immunotherapy in bladder cancer
-
0:53
keynote-522 demonstrates potential for immunotherapy in triple-negative breast cancer
-
2:15
dr. wakelee on birch trial for atezolizumab in patients with nsclc
-
2:53
immunotherapy: a revolution in cancer treatment
-
3:10
fastest cancer drug, very easy to administer, reduced discomfort, and shorten duration of treatment
-
1:12
cityscape: 1l tiragolumab atezolizumab vs placebo atezolizumab in pd-l1-selected nsclc
-
1:03
sangeetha palakurthi on fda approval of atezolizumab in nsclc
-
1:27
dr. rini on the tolerability of atezolizumab plus bevacizumab in rcc
-
9:24
impower010 supports adjuvant atezolizumab in early-stage nsclc | heather wakelee
-
3:12
atezolizumab with nab-paclitaxel improves survival in breast cancer patients
-
1:50
dr. melissa johnson on atezolizumab in patients with nsclc
-
3:07
neoadjuvant atezolizumab in nsclc
-
2:36
unexpected safety data in treasure: thoracic radiotherapy with atezolizumab in sclc
-
0:54
celebrate: carboplatin, etoposide, bevacizumab and atezolizumab in extensive-stage sclc
-
0:50
dr. petrylak on atezolizumab in bladder cancer